LIWANLI Innovation Co., Ltd. (TPE:3054)
51.50
-2.20 (-4.10%)
Aug 19, 2026, 1:30 PM CST
LIWANLI Innovation Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 414.67 | 125.54 | 99.16 | 38.89 | 33.99 | 47.81 |
Revenue Growth | 355.60% | 26.61% | 154.98% | 14.41% | -28.92% | -82.73% |
Gross Profit Gross Profit Growth | 207.46 | 39.11 | 20.83 | 15.08 | 11.39 | 7.54 |
Operating Income Operating Income Growth | 74.53 | -70.83 | -37.35 | -39.78 | -40.15 | -48.64 |
Net Income Net Income Growth | 391.73 | 158.15 | -32.07 | 5.1 | -120.91 | 45.56 |
Earnings Per Share EPS Growth | 4.78 | 1.94 | -0.40 | 0.06 | -1.50 | 0.55 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Biotechnology Growth | 37.81 | 44.02 | 38.77 | 34.1 | 33.88 | 47.45 |
Electronics Electronics Growth | 376.85 | 81.52 | 60.39 | 4.79 | 0.11 | 0.37 |
Total Total Growth | 414.67 | 125.54 | 99.16 | 38.89 | 33.99 | 47.81 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 710.73 | 446.68 | 337.68 | 356.41 | 386.3 | 511.55 |
Total Debt Total Debt Growth | 1.02 | 1.23 | 0.36 | 0.84 | 1.31 | 1.28 |
Net Cash (Debt) Net Cash Growth | 709.71 | 445.45 | 337.32 | 355.58 | 384.99 | 510.27 |
Net Cash Growth | 135.90% | 32.06% | -5.13% | -7.64% | -24.55% | 16.33% |
Net Cash Per Share Net Cash Per Share Growth | 8.65 | 5.45 | 4.18 | 4.41 | 4.77 | 6.17 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 150.29 | -71.75 | 14.2 | -50.34 | 78.48 | -61.13 |
Capital Expenditures CapEx Growth | -0.3 | -4.05 | -8.53 | - | - | -1.96 |
Free Cash Flow Free Cash Flow Growth | 149.99 | -75.81 | 5.67 | -50.34 | 78.48 | -63.09 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.03% | 31.15% | 21.01% | 38.79% | 33.52% | 15.77% |
Operating Margin | 17.97% | -56.42% | -37.66% | -102.30% | -118.11% | -101.73% |
Pretax Margin | 99.61% | 126.06% | -31.17% | 12.14% | -353.81% | 119.72% |
Profit Margin | 94.47% | 125.97% | -32.35% | 13.12% | -355.73% | 95.29% |
FCF Margin | 36.17% | -60.39% | 5.72% | -129.46% | 230.90% | -131.95% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 1.49% | 2.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.77 | 16.55 | - | 331.90 | - | 46.17 |
P/FCF Ratio | 27.69 | - | 350.69 | - | 20.50 | - |
PS Ratio | 10.02 | 20.85 | 20.05 | 43.55 | 47.34 | 44.00 |